Recent advancements in the field of diabetes treatment have introduced a promising class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://maeexzf651998.blogcudinti.com/41369983/novel-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide